Palisade Bio (PALI) Total Liabilities (2010 - 2026)

Palisade Bio (PALI) has 17 years of Total Liabilities data on file, last reported at $6.0 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 108.22% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $6.0 million, a 108.22% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 46.52% from the prior year.
• Total Liabilities for Q1 2026 stood at $6.0 million, up from $5.0 million in the prior quarter.
• Over the last five years, Total Liabilities for PALI reached as high as $6.0 million in Q1 2026 and fell as low as $1.5 million in Q1 2023.
• Historically, Total Liabilities has averaged $3.4 million across 5 years, with a median of $3.3 million in 2022.
• On a YoY basis, Total Liabilities climbed as much as 199.97% in 2022 and fell as far as 85.26% in 2022.
• Year by year, Total Liabilities stood at $3.3 million in 2022, then declined by 16.6% to $2.7 million in 2023, then gained by 23.69% to $3.4 million in 2024, then jumped by 46.52% to $5.0 million in 2025, then gained by 19.92% to $6.0 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $6.0 million in Q1 2026, $5.0 million in Q4 2025, and $3.8 million in Q3 2025.